COMMUNIQUÉS West-GlobeNewswire

XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer
02/04/2018
AUSTIN, Texas, April 02, 2018 (GLOBE NEWSWIRE) -- XBiotech USA, Inc. (NASDAQ: XBIT ) announced today that it has obtained an exclusive, worldwide license from CT Atlantic AG (CTA), a Swiss biotechnology company. Under [...]
Women In Bio Closes Boardroom Ready 2018 Applications and Celebrates Board Appointments of Program Alumni
02/04/2018
NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- Women In Bio (WIB), an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences, has closed the [...]
Idera Pharmaceuticals Files Definitive Proxy Statement in Connection with Pending Merger with BioCryst Pharmaceuticals
02/04/2018
EXTON, Pa., April 02, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ) (“Idera”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel [...]
Rhythm Pharmaceuticals Announces Licensing Agreement with Takeda for the Development and Commercialization of Preclinical Treatment for Prader-Willi Syndrome
02/04/2018
-- Oral Ghrelin O-Acyltransferase (GOAT) Inhibitor Complements and Expands Efforts in Prader-Willi Syndrome -- -- In Preclinical Models, Prevented Body Weight Gain and Reduced Fat Mass -- -- Rhythm Expects to File [...]
Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase in Both Monotherapy and KEYTRUDA® (Pembrolizumab) Combination Trials
02/04/2018
AUSTIN, Texas, April 02, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures
02/04/2018
LAVAL, Québec, April 02, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Corporation”) (NASDAQ: ACST ) (TSX-V: ACST ) announces that in accordance with the terms of its outstanding convertible debentures [...]
Emerald Health Therapeutics Reports 2017 Financial Results and Provides Corporate Update
02/04/2018
VICTORIA, British Columbia, April 02, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (“Emerald” or “the Company”) has filed its audited financial statements and management discussion [...]
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
02/04/2018
REDWOOD CITY, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases [...]
Inovio Pharmaceuticals to Present at the H.C. Wainwright Annual Global Life Sciences Conference
02/04/2018
PLYMOUTH MEETING, Pa., April 02, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that Dr. J. Joseph Kim, Inovio’s President & CEO, will provide a corporate overview at the H.C. [...]
Abiomed Receives FDA Approval for Impella CP® with SmartAssist™ and Optical Sensor
02/04/2018
DANVERS, Mass., April 02, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support and recovery technologies, announced today that it has received U.S. Food and Drug [...]
Synergy CHC Corp. Announces Fiscal 2017 Year End Results
02/04/2018
Westbrook, Maine, April 02, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the fiscal year ended December [...]
Strongbridge Biopharma plc Announces Dosing of First Four Patients in LOGICS, a Second Global Phase 3 Study of RECORLEV™ (levoketoconazole) in Endogenous Cushing’s Syndrome
02/04/2018
DUBLIN, Ireland and TREVOSE, Pa., April 02, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Neuralstem Reports Year End 2017 Fiscal Results and Business Update
02/04/2018
- Neuralstem Releases Full Data Set for NSI-189 MDD Trial Showing Patient Rated Outcome and Cognitive Benefits - Nature Medicine Paper Demonstrates Benefit of NSI-566 on Paralysis in Non-Human Primates GERMANTOWN, Md., [...]
Myriad Receives Pre-Market Approval for its BRACAnalysis® Diagnostic System in Japan
02/04/2018
SALT LAKE CITY, April 02, 2018 (GLOBE NEWSWIRE) -- Myriad Genetic Laboratories, Inc., a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ: MYGN ), announced today that the Japanese Ministry of Health, Labour, and [...]
Tetraphase Pharmaceuticals to Present at H.C. Wainwright Annual Global Life Sciences Conference
02/04/2018
WATERTOWN, Mass., April 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ) a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant [...]
Eyenovia Announces Fourth Quarter and Full Year 2017 Financial Results
02/04/2018
NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to [...]
PotNetwork Holding's Diamond CBD Breaks into Untapped African Continent
02/04/2018
FT LAUDERDALE, Fla., April 02, 2018 (GLOBE NEWSWIRE) -- PotNetwork Holding, Inc. (OTC Pink:POTN) On Monday, April 2nd, 2018, PotNetwork Holding Inc.'s wholly owned subsidiary, Diamond CBD Inc. announces plans to kick [...]
MediciNova Announces Phase 2 Trial of MN-001 (tipelukast) in NASH / NAFLD will be Terminated Early based on Significant Positive Results from Interim Analysis
02/04/2018
LA JOLLA, Calif., April 01, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Le Groupe Jean Coutu – Dividende quatrième trimestre de l’exercice financier 2018
01/04/2018
VARENNES, Québec, 01 avr. 2018 (GLOBE NEWSWIRE) -- Le Groupe Jean Coutu (PJC) inc. (la « Société » ou le « Groupe Jean Coutu ») (TSX:PJC.A) annonce que son conseil d’administration a déclaré aujourd’hui un dividende de [...]

Pages